US 9193722
Tri-cyclic pyrazolopyridine kinase inhibitors
granted A61KA61K31/496A61K31/506
Quick answer
US patent 9193722 (Tri-cyclic pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/496, A61K31/506, A61P, A61P1/00